2 results
Approved WMOCompleted
What is the prevalence of gastro-intestinal disorders and which are the determinants?
Approved WMOCompleted
To evaluate the feasibility of 89Zr-bevacizumab-PET imaging as predictive biomarker before and during treatment with everolimus in patients with neuroendocrine tumors.